Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 506

1.

Post-procedure protocol to facilitate next-day discharge: Results of the multidisciplinary, multimodality but minimalist TAVR study.

Lauck SB, Sathananthan J, Park J, Achtem L, Smith A, Keegan P, Hawkey M, Brandwein R, Webb JG, Wood DA; 3M TAVR Investigators, and Nursing and Allied Health Professional Site Leaders.

Catheter Cardiovasc Interv. 2019 Nov 29. doi: 10.1002/ccd.28617. [Epub ahead of print]

PMID:
31785087
2.

Valve-in-Valve Implantation Using the ACURATE Neo in Degenerated Aortic Bioprostheses: An International Multicenter Analysis.

Holzamer A, Kim WK, Rück A, Sathananthan J, Keller L, Cosma J, Bauer T, Nef H, Amat-Santos IJ, Brinkert M, Husser O, Pellegrini C, Schofer J, Nerla R, Montorfano M, Giannini F, Stella P, Kuwata S, Hilker M, Castriota F, Ussia GP, Webb JG, Nietlispach F, Toggweiler S.

JACC Cardiovasc Interv. 2019 Nov 25;12(22):2309-2316. doi: 10.1016/j.jcin.2019.07.042.

PMID:
31753302
3.

Residual challenges in TAVI: moving forward.

Barbanti M, Webb JG, Dvir D, Prendergast BD.

EuroIntervention. 2019 Nov 20;15(10):857-866. doi: 10.4244/EIJ-D-19-00788. Review.

4.

Prosthetic Valve Endocarditis After TAVR and SAVR: Insights From the PARTNER Trials.

Summers MR, Leon MB, Smith CR, Kodali SK, Thourani VH, Herrmann HC, Makkar RR, Pibarot P, Webb JG, Leipsic J, Alu MC, Crowley A, Hahn RT, Kapadia SR, Tuzcu EM, Svensson L, Cremer PC, Jaber WA.

Circulation. 2019 Dec 10;140(24):1984-1994. doi: 10.1161/CIRCULATIONAHA.119.041399. Epub 2019 Nov 6.

PMID:
31690104
5.

2019 Canadian Cardiovascular Society Position Statement for Transcatheter Aortic Valve Implantation.

Asgar AW, Ouzounian M, Adams C, Afilalo J, Fremes S, Lauck S, Leipsic J, Piazza N, Rodes-Cabau J, Welsh R, Wijeysundera HC, Webb JG.

Can J Cardiol. 2019 Nov;35(11):1437-1448. doi: 10.1016/j.cjca.2019.08.011.

PMID:
31679616
6.

Implications of hydrodynamic testing to guide sizing of self-expanding transcatheter heart valves for valve-in-valve procedures.

Sathananthan J, Hensey M, Fraser R, Landes U, Blanke P, Hatoum H, Dasi LP, Sedaghat A, Bapat VN, Leipsic J, Søndergaard L, Wood DA, Webb JG.

Catheter Cardiovasc Interv. 2019 Oct 24. doi: 10.1002/ccd.28537. [Epub ahead of print]

PMID:
31647178
7.

Impact of implant depth on hydrodynamic function with the ALLEGRA transcatheter heart valve following valve-in-valve intervention.

Sathananthan J, Fraser R, Kütting M, Hensey M, Landes U, Alkhodair A, Sedaghat A, Blanke P, Toggweiler S, Leipsic J, Søndergaard L, Wood D, Webb JG.

EuroIntervention. 2019 Oct 15. pii: EIJ-D-19-00782. doi: 10.4244/EIJ-D-19-00782. [Epub ahead of print]

8.

Health Status After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis.

Baron SJ, Magnuson EA, Lu M, Wang K, Chinnakondepalli K, Mack M, Thourani VH, Kodali S, Makkar R, Herrmann HC, Kapadia S, Babaliaros V, Williams MR, Kereiakes D, Zajarias A, Alu MC, Webb JG, Smith CR, Leon MB, Cohen DJ; PARTNER 3 Investigators.

J Am Coll Cardiol. 2019 Dec 10;74(23):2833-2842. doi: 10.1016/j.jacc.2019.09.007. Epub 2019 Sep 29.

PMID:
31577923
9.

Long-Term Durability of Transcatheter Heart Valves: Insights From Bench Testing to 25 Years.

Sathananthan J, Hensey M, Landes U, Alkhodair A, Saiduddin A, Sellers S, Cheung A, Lauck S, Blanke P, Leipsic J, Ye J, Wood DA, Webb JG.

JACC Cardiovasc Interv. 2019 Sep 21. pii: S1936-8798(19)31658-9. doi: 10.1016/j.jcin.2019.07.049. [Epub ahead of print]

PMID:
31575516
10.

The final meta-analysis?

Webb JG, Landes U.

Eur Heart J. 2019 Oct 7;40(38):3154-3155. doi: 10.1093/eurheartj/ehz696. No abstract available.

PMID:
31573604
11.

Transcatheter versus medical treatment of symptomatic severe tricuspid regurgitation.

Taramasso M, Benfari G, van der Bijl P, Alessandrini H, Attinger-Toller A, Biasco L, Lurz P, Braun D, Brochet E, Connelly KA, de Bruijn S, Denti P, Deuschl F, Estevez-Loureiro R, Fam N, Frerker C, Gavazzoni M, Hausleiter JR, Ho E, Juliard JM, Kaple R, Besler C, Kodali S, Kreidel F, Kuck KH, Latib A, Lauten A, Monivas V, Mehr M, Muntané-Carol G, Nazif T, Nickening G, Pedrazzini G, Philippon F, Pozzoli A, Praz F, Puri R, Rodés-Cabau J, Scha Fer U, Schofer J, Sievert H, Tang GHL, Thiele H, Topilsky Y, Rommel KP, Delgado V, Vahanian A, Von Bardeleben RS, Webb JG, Weber M, Windecker S, Winkel M, Zuber M, Leon MB, Hahn RT, Bax JJ, Enriquez-Sarano M, Maisano F.

J Am Coll Cardiol. 2019 Sep 24. pii: S0735-1097(19)37739-3. doi: 10.1016/j.jacc.2019.09.028. [Epub ahead of print]

PMID:
31568868
12.

New-onset left bundle branch block after transcatheter aortic valve replacement is associated with adverse long-term clinical outcomes in intermediate-risk patients: an analysis from the PARTNER II trial.

Nazif TM, Chen S, George I, Dizon JM, Hahn RT, Crowley A, Alu MC, Babaliaros V, Thourani VH, Herrmann HC, Smalling RW, Brown DL, Mack MJ, Kapadia S, Makkar R, Webb JG, Leon MB, Kodali SK.

Eur Heart J. 2019 Jul 14;40(27):2218-2227. doi: 10.1093/eurheartj/ehz227.

PMID:
31505615
13.

Mid-term outcome in patients with bicuspid aortic valve stenosis following transcatheter aortic valve replacement with a current generation device: A multicenter study.

Attinger-Toller A, Bhindi R, Perlman GY, Murdoch D, Weir-McCall J, Blanke P, Barbanti M, Sathananthan J, Ruile P, Gandolfo C, Saia F, Nietlispach F, Wood D, Leipsic J, Webb JG.

Catheter Cardiovasc Interv. 2019 Sep 4. doi: 10.1002/ccd.28475. [Epub ahead of print]

PMID:
31483555
14.

Long-Term Outcomes of the FORMA Transcatheter Tricuspid Valve Repair System for the Treatment of Severe Tricuspid Regurgitation: Insights From the First-in-Human Experience.

Asmarats L, Perlman G, Praz F, Hensey M, Chrissoheris MP, Philippon F, Ofek H, Ye J, Puri R, Pibarot P, Attinger A, Moss R, Bédard E, Moschovitis A, Reineke D, Lauck S, Blanke P, Leipsic J, Spargias K, Windecker S, Webb JG, Rodés-Cabau J.

JACC Cardiovasc Interv. 2019 Aug 12;12(15):1438-1447. doi: 10.1016/j.jcin.2019.04.038.

PMID:
31395213
15.

Transcatheter heart valve migration and embolization: rare and preventable?

Binder RK, Webb JG.

Eur Heart J. 2019 Oct 7;40(38):3166-3168. doi: 10.1093/eurheartj/ehz562. No abstract available.

PMID:
31377802
16.

Inter- and intrasite variability of mortality and stroke for sites performing both surgical and transcatheter aortic valve replacement for aortic valve stenosis in intermediate-risk patients.

Greason KL, Blackstone EH, Rajeswaran J, Lowry AM, Svensson LG, Webb JG, Tuzcu EM, Smith CR, Makkar RR, Mack MJ, Thourani VH, Kodali SK, Leon MB, Miller DC.

J Thorac Cardiovasc Surg. 2019 Jun 15. pii: S0022-5223(19)31209-7. doi: 10.1016/j.jtcvs.2019.04.112. [Epub ahead of print]

PMID:
31350027
17.

Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Percutaneous Vascular Closure Device.

Wood DA, Krajcer Z, Sathananthan J, Strickman N, Metzger C, Fearon W, Aziz M, Satler LF, Waksman R, Eng M, Kapadia S, Greenbaum A, Szerlip M, Heimansohn D, Sampson A, Coady P, Rodriguez R, Krishnaswamy A, Lee JT, Ben-Dor I, Moainie S, Kodali S, Chhatriwalla AK, Yadav P, O'Neill B, Kozak M, Bacharach JM, Feldman T, Guerrero M, Nanjundappa A, Bersin R, Zhang M, Potluri S, Barker C, Bernardo N, Lumsden A, Barleben A, Campbell J, Cohen DJ, Dake M, Brown D, Maor N, Nardone S, Lauck S, O'Neill WW, Webb JG; SAFE MANTA Study Investigators.

Circ Cardiovasc Interv. 2019 Jul;12(7):e007258. doi: 10.1161/CIRCINTERVENTIONS.119.007258. Epub 2019 Jul 12.

PMID:
31296082
18.

Transcatheter Valves Get More Complicated.

Webb JG, Hensey M.

JACC Cardiovasc Interv. 2019 Jul 8;12(13):1238-1239. doi: 10.1016/j.jcin.2019.05.007. No abstract available.

PMID:
31272670
19.

Transcatheter Valve Repair for Patients With Mitral Regurgitation: 30-Day Results of the CLASP Study.

Lim DS, Kar S, Spargias K, Kipperman RM, O'Neill WW, Ng MKC, Fam NP, Walters DL, Webb JG, Smith RL, Rinaldi MJ, Latib A, Cohen GN, Schäfer U, Marcoff L, Vandrangi P, Verta P, Feldman TE.

JACC Cardiovasc Interv. 2019 Jul 22;12(14):1369-1378. doi: 10.1016/j.jcin.2019.04.034. Epub 2019 Jun 26.

PMID:
31255562
20.

Transcatheter Aortic Valve Replacement Outcomes in Patients With Native vs Transplanted Kidneys: Data From an International Multicenter Registry.

Witberg G, Shamekhi J, Van Mieghem NM, Ferrero-Guadagnoli A, Soendergaard L, Dvir D, Latib A, Testa L, Guerrero M, Piazza N, Bleiziffer S, Webb JG, Barbash I, Finkelstein A, Makkar R, Mylotte D, Sinning JM, El Faquir N, Masiano F, De Backer O, Birs A, Lanzillo G, Bedogni F, Iftikhar O, Pighi M, Deutsch MA, Attinger-Toller A, Maor E, Rozenbaum Z, Yoon SH, Neylon A, Kornowski R.

Can J Cardiol. 2019 Sep;35(9):1114-1123. doi: 10.1016/j.cjca.2019.01.003. Epub 2019 Jan 18.

PMID:
31202537
21.

Assessment of Updated Society of Thoracic Surgeons Score in Historical PARTNER II Patients.

Hensey M, Sathananthan J, Murdoch DJ, Alkhodair A, Ye J, Cheung A, Blanke P, Leipsic J, Wood DA, Webb JG.

J Am Coll Cardiol. 2019 Jun 18;73(23):3032-3034. doi: 10.1016/j.jacc.2019.03.498. No abstract available.

PMID:
31196463
22.

Profiling Hospital Performance on the Basis of Readmission After Transcatheter Aortic Valve Replacement in Ontario, Canada.

Elbaz-Greener G, Qiu F, Webb JG, Henning KA, Ko DT, Czarnecki A, Roifman I, Austin PC, Wijeysundera HC.

J Am Heart Assoc. 2019 Jun 18;8(12):e012355. doi: 10.1161/JAHA.119.012355. Epub 2019 Jun 5.

23.

3-Year Outcomes After Valve-in-Valve Transcatheter Aortic Valve Replacement for Degenerated Bioprostheses: The PARTNER 2 Registry.

Webb JG, Murdoch DJ, Alu MC, Cheung A, Crowley A, Dvir D, Herrmann HC, Kodali SK, Leipsic J, Miller DC, Pibarot P, Suri RM, Wood D, Leon MB, Mack MJ.

J Am Coll Cardiol. 2019 Jun 4;73(21):2647-2655. doi: 10.1016/j.jacc.2019.03.483.

PMID:
31146808
24.

Fracture of small Mitroflow® aortic bioprosthesis following valve-in-valve transcatheter aortic valve replacement with ACURATE neo valve-From bench testing to clinical practice.

Amat-Santos IJ, Gutiérrez H, Sathananthan J, Webb JG.

Catheter Cardiovasc Interv. 2019 May 29. doi: 10.1002/ccd.28347. [Epub ahead of print]

PMID:
31140682
25.

Impact of Local Anesthesia Only Versus Procedural Sedation Using the Vancouver Clinical Pathway for TAVR: Insights From the 3M TAVR Study.

Sathananthan J, Webb JG, Lauck SB, Cairns J, Humphries KH, Nazif T, Thourani VH, Cohen DJ, Leon MB, Wood DA; 3M TAVR Study Investigators.

JACC Cardiovasc Interv. 2019 May 27;12(10):1000-1001. doi: 10.1016/j.jcin.2019.02.014. No abstract available.

PMID:
31122345
26.

Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: A post hoc analysis from the BRAVO-3 randomized trial.

Power D, Schäfer U, Guedeney P, Claessen BE, Sartori S, Sorrentino S, Lefèvre T, Kupatt C, Tchetche D, Dumonteil N, Webb JG, Colombo A, Windecker S, Ten Berg JM, Hildick-Smith D, Boekstegers P, Linke A, Tron C, Van Belle E, Asgar AW, Jeger R, Sardella G, Hink U, Husser O, Grube E, Lechthaler I, Wijngaard P, Anthopoulos P, Deliargyris EN, Bernstein D, Hengstenberg C, Mehran R, Dangas GD.

Catheter Cardiovasc Interv. 2019 Jun 1;93(7):1374-1381. doi: 10.1002/ccd.28295. Epub 2019 May 22.

PMID:
31116908
27.

Increasing awareness of the need to protect the coronary arteries in patients with failed surgical and transcatheter aortic valves.

Webb JG, Sathananthan J, Wood DA.

EuroIntervention. 2019 May 20;15(1):21-23. doi: 10.4244/EIJV15I1A3. No abstract available.

28.

Transcatheter Aortic-Valve Replacement - 10 Years Later.

Murdoch DJ, Webb JG, Ye J, Sathananthan J, Hensey M, Wood DA, Cheung A, Leipsic J, Blanke P, Lauck S.

N Engl J Med. 2019 May 2;380(18):1773-1774. doi: 10.1056/NEJMc1814932. No abstract available.

PMID:
31042832
29.

Transcatheter aortic valve-in-valve implantation for failed surgical bioprosthetic valves. A minimalist approach without contrast aortography or echocardiographic guidance.

Attinger-Toller A, Htun NM, Murdoch D, Perlman GY, Alenezi A, Sathananthan J, Blanke P, Leipsic J, Thompson C, Ye J, Cheung A, Wood D, Webb JG.

Catheter Cardiovasc Interv. 2019 Apr 30. doi: 10.1002/ccd.28299. [Epub ahead of print]

PMID:
31038290
30.

Early experience with a purpose-designed temporary pacing guidewire for transcatheter valve implantation.

Hensey M, Daniels D, Wood D, Webb JG.

EuroIntervention. 2019 Aug 9;15(6):e508-e509. doi: 10.4244/EIJ-D-19-00138. No abstract available.

31.

Habitual Physical Activity in Older Adults Undergoing TAVR: Insights From the FRAILTY-AVR Study.

Sathananthan J, Lauck S, Piazza N, Martucci G, Kim DH, Popma JJ, Asgar AW, Perrault LP, Lefèvre T, Labinaz M, Lamy A, Peterson MD, Arora RC, Noiseux N, Généreux P, Webb JG, Afilalo J.

JACC Cardiovasc Interv. 2019 Apr 22;12(8):781-789. doi: 10.1016/j.jcin.2019.02.049.

PMID:
31000014
32.

Impact of Chronic Kidney Disease on Decision Making and Management in Transcatheter Aortic Valve Interventions.

Hensey M, Murdoch DJ, Sathananthan J, Wood DA, Webb JG.

Can J Cardiol. 2019 Sep;35(9):1188-1194. doi: 10.1016/j.cjca.2018.11.010. Epub 2018 Nov 24. Review.

PMID:
30910248
33.

Percutaneous Transcatheter Mitral Valve Replacement: First-in-Human Experience With a New Transseptal System.

Webb JG, Murdoch DJ, Boone RH, Moss R, Attinger-Toller A, Blanke P, Cheung A, Hensey M, Leipsic J, Ong K, Sathananthan J, Wood DA, Ye J, Tartara P.

J Am Coll Cardiol. 2019 Mar 26;73(11):1239-1246. doi: 10.1016/j.jacc.2018.12.065.

PMID:
30898198
34.

Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients.

Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, Kapadia SR, Malaisrie SC, Cohen DJ, Pibarot P, Leipsic J, Hahn RT, Blanke P, Williams MR, McCabe JM, Brown DL, Babaliaros V, Goldman S, Szeto WY, Genereux P, Pershad A, Pocock SJ, Alu MC, Webb JG, Smith CR; PARTNER 3 Investigators.

N Engl J Med. 2019 May 2;380(18):1695-1705. doi: 10.1056/NEJMoa1814052. Epub 2019 Mar 16.

PMID:
30883058
35.

Sex-Specific Determinants of Outcomes After Transcatheter Aortic Valve Replacement.

Pighi M, Piazza N, Martucci G, Lachapelle K, Perrault LP, Asgar AW, Lauck S, Webb JG, Popma JJ, Kim DH, Lefèvre T, Labinaz M, Lamy A, Peterson MD, Arora RC, Noiseux N, Trnkus A, Afilalo J.

Circ Cardiovasc Qual Outcomes. 2019 Mar;12(3):e005363. doi: 10.1161/CIRCOUTCOMES.118.005363.

PMID:
30879326
36.

The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers: The 3M TAVR Study.

Wood DA, Lauck SB, Cairns JA, Humphries KH, Cook R, Welsh R, Leipsic J, Genereux P, Moss R, Jue J, Blanke P, Cheung A, Ye J, Dvir D, Umedaly H, Klein R, Rondi K, Poulter R, Stub D, Barbanti M, Fahmy P, Htun N, Murdoch D, Prakash R, Barker M, Nickel K, Thakkar J, Sathananthan J, Tyrell B, Al-Qoofi F, Velianou JL, Natarajan MK, Wijeysundera HC, Radhakrishnan S, Horlick E, Osten M, Buller C, Peterson M, Asgar A, Palisaitis D, Masson JB, Kodali S, Nazif T, Thourani V, Babaliaros VC, Cohen DJ, Park JE, Leon MB, Webb JG.

JACC Cardiovasc Interv. 2019 Mar 11;12(5):459-469. doi: 10.1016/j.jcin.2018.12.020.

PMID:
30846085
37.

Transcatheter Aortic Valve Replacement With Next-Generation Self-Expanding Devices: A Multicenter, Retrospective, Propensity-Matched Comparison of Evolut PRO Versus Acurate neo Transcatheter Heart Valves.

Pagnesi M, Kim WK, Conradi L, Barbanti M, Stefanini GG, Zeus T, Pilgrim T, Schofer J, Zweiker D, Testa L, Taramasso M, Hildick-Smith D, Abizaid A, Wolf A, Van Mieghem NM, Sedaghat A, Wöhrle J, Khogali S, Van der Heyden JAS, Webb JG, Estévez-Loureiro R, Mylotte D, MacCarthy P, Brugaletta S, Hamm CW, Bhadra OD, Schäfer U, Costa G, Tamburino C, Cannata F, Reimers B, Veulemans V, Asami M, Windecker S, Eitan A, Schmidt A, Bianchi G, Bedogni F, Saccocci M, Maisano F, Alsanjari O, Siqueira D, Jensen CJ, Naber CK, Ziviello F, Sinning JM, Seeger J, Rottbauer W, Brouwer J, Alenezi A, Wood DA, Tzalamouras V, Regueiro A, Colombo A, Latib A.

JACC Cardiovasc Interv. 2019 Mar 11;12(5):433-443. doi: 10.1016/j.jcin.2018.11.036.

PMID:
30846081
38.

Valve-in-Valve Transcatheter Aortic Valve Replacement and Bioprosthetic Valve Fracture Comparing Different Transcatheter Heart Valve Designs: An Ex Vivo Bench Study.

Sathananthan J, Sellers S, Barlow AM, Stanová V, Fraser R, Toggweiler S, Allen KB, Chhatriwalla A, Murdoch DJ, Hensey M, Lau K, Alkhodair A, Dvir D, Asgar AW, Cheung A, Blanke P, Ye J, Rieu R, Pibarot P, Wood D, Leipsic J, Webb JG.

JACC Cardiovasc Interv. 2019 Jan 14;12(1):65-75. doi: 10.1016/j.jcin.2018.10.043.

PMID:
30621980
39.

The Lotus Valve Is Safe and Effective, But Will Atrioventricular Block Improve With the Next-Generation System?

Webb JG, Sathananthan J.

JACC Cardiovasc Interv. 2019 Jan 14;12(1):50-51. doi: 10.1016/j.jcin.2018.11.010. No abstract available.

PMID:
30621977
40.

Association Between Wait Time for Transcatheter Aortic Valve Replacement and Early Postprocedural Outcomes.

Elbaz-Greener G, Yarranton B, Qiu F, Wood DA, Webb JG, Fremes SE, Radhakrishnan S, Wijeysundera HC.

J Am Heart Assoc. 2019 Jan 8;8(1):e010407. doi: 10.1161/JAHA.118.010407.

41.

Outcomes After Current Transcatheter Tricuspid Valve Intervention: Mid-Term Results From the International TriValve Registry.

Taramasso M, Alessandrini H, Latib A, Asami M, Attinger-Toller A, Biasco L, Braun D, Brochet E, Connelly KA, Denti P, Deuschl F, Englmeier A, Fam N, Frerker C, Hausleiter J, Himbert D, Ho EC, Juliard JM, Kaple R, Kreidel F, Kuck KH, Ancona M, Lauten A, Lurz P, Mehr M, Nazif T, Nickening G, Pedrazzini G, Pozzoli A, Praz F, Puri R, Rodés-Cabau J, Schäfer U, Schofer J, Sievert H, Sievert K, Tang GHL, Tanner FC, Vahanian A, Webb JG, Windecker S, Yzeiray E, Zuber M, Maisano F, Leon MB, Hahn RT.

JACC Cardiovasc Interv. 2019 Jan 28;12(2):155-165. doi: 10.1016/j.jcin.2018.10.022. Epub 2018 Dec 26.

PMID:
30594510
42.

Clinical Valve Thrombosis After Transcatheter Aortic Valve-in-Valve Implantation.

Abdel-Wahab M, Simonato M, Latib A, Goleski PJ, Allali A, Kaur J, Azadani AN, Horlick E, Testa L, Orvin K, Kornowski R, Kass M, Don CW, Richardt G, Webb JG, Dvir D.

Circ Cardiovasc Interv. 2018 Nov;11(11):e006730. doi: 10.1161/CIRCINTERVENTIONS.118.006730.

PMID:
30571208
43.

Impact of Preexisting Left Bundle Branch Block in Transcatheter Aortic Valve Replacement Recipients.

Fischer Q, Himbert D, Webb JG, Eltchaninoff H, Muñoz-García AJ, Tamburino C, Nombela-Franco L, Nietlispach F, Moris C, Ruel M, Dager AE, Serra V, Cheema AN, Amat-Santos IJ, de Brito FS, Ribeiro H, Abizaid A, Sarmento-Leite R, Dumont E, Barbanti M, Durand E, Alonso Briales JH, Bouleti C, Immè S, Maisano F, Del Valle R, Miguel Benitez L, García Del Blanco B, Côté M, Philippon F, Urena M, Rodés-Cabau J.

Circ Cardiovasc Interv. 2018 Nov;11(11):e006927. doi: 10.1161/CIRCINTERVENTIONS.118.006927.

PMID:
30571207
44.

Profiling Hospital Performance Based on Mortality After Transcatheter Aortic Valve Replacement in Ontario, Canada.

Elbaz-Greener G, Qiu F, Masih S, Fang J, Austin PC, Cantor WJ, Dvir D, Asgar AW, Webb JG, Ko DT, Wijeysundera HC.

Circ Cardiovasc Qual Outcomes. 2018 Dec;11(12):e004947. doi: 10.1161/CIRCOUTCOMES.118.004947.

PMID:
30562064
45.

Transcatheter valve-in-valve implantation for degenerated surgical bioprostheses.

Murdoch DJ, Webb JG.

J Thorac Dis. 2018 Nov;10(Suppl 30):S3573-S3577. doi: 10.21037/jtd.2018.05.66. Review.

46.

Impact of implant depth on hydrodynamic function with the ACURATE <i>neo</i> transcatheter heart valve following valve-in-valve transcatheter aortic valve replacement in Mitroflow bioprosthetic valves: an ex vivo bench study.

Sathananthan J, Sellers SL, Fraser R, Dvir D, Hensey M, Murdoch DJ, Blanke P, Pibarot P, Toggweiler S, Wood D, Leipsic J, Webb JG.

EuroIntervention. 2019 May 20;15(1):78-87. doi: 10.4244/EIJ-D-18-00947.

47.

First-in-human experience of a new-generation transfemoral transcatheter aortic valve for the treatment of severe aortic regurgitation: the J-Valve transfemoral system.

Hensey M, Murdoch DJ, Sathananthan J, Alenezi A, Sathananthan G, Moss R, Blanke P, Leipsic J, Wood DA, Cheung A, Ye J, Webb JG.

EuroIntervention. 2019 Feb 8;14(15):e1553-e1555. doi: 10.4244/EIJ-D-18-00935. No abstract available.

48.

Transcatheter Aortic Heart Valves: Histological Analysis Providing Insight to Leaflet Thickening and Structural Valve Degeneration.

Sellers SL, Turner CT, Sathananthan J, Cartlidge TRG, Sin F, Bouchareb R, Mooney J, Nørgaard BL, Bax JJ, Bernatchez PN, Dweck MR, Granville DJ, Newby DE, Lauck S, Webb JG, Payne GW, Pibarot P, Blanke P, Seidman MA, Leipsic JA.

JACC Cardiovasc Imaging. 2019 Jan;12(1):135-145. doi: 10.1016/j.jcmg.2018.06.028. Epub 2018 Nov 15.

PMID:
30448122
49.

Stroke After Surgical Versus Transfemoral Transcatheter Aortic Valve Replacement in the PARTNER Trial.

Kapadia SR, Huded CP, Kodali SK, Svensson LG, Tuzcu EM, Baron SJ, Cohen DJ, Miller DC, Thourani VH, Herrmann HC, Mack MJ, Szerlip M, Makkar RR, Webb JG, Smith CR, Rajeswaran J, Blackstone EH, Leon MB; PARTNER Trial Investigators.

J Am Coll Cardiol. 2018 Nov 13;72(20):2415-2426. doi: 10.1016/j.jacc.2018.08.2172.

50.

Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Cardiac Surgery in the Randomized PARTNER 2A Trial.

Chen S, Redfors B, Ben-Yehuda O, Crowley A, Greason KL, Alu MC, Finn MT, Vahl TP, Nazif T, Thourani VH, Suri RM, Svensson L, Webb JG, Kodali SK, Leon MB.

JACC Cardiovasc Interv. 2018 Nov 12;11(21):2207-2216. doi: 10.1016/j.jcin.2018.08.006. Epub 2018 Aug 28.

Supplemental Content

Support Center